{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 Cortisol"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products Ltd.",
    "510(k) Number": "K202826",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931409"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGR"
    ],
    "Summary Letter Date": "September 22, 2020",
    "Summary Letter Received Date": "September 24, 2020",
    "Submission Date": "January 8, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1205"
    ],
    "Regulation Name(s)": [
        "Cortisol (Hydrocortisone And Hydroxycorticosterone) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Cortisol"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE\u00ae 2000 Systems Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE\u00ae 2000 Cortisol chemiluminescent immunoassay for quantitative serum cortisol measurement",
    "Indications for Use Summary": "For in vitro diagnostic use with the IMMULITE\u00ae 2000 Systems Analyzer for the quantitative measurement of cortisol in serum as an aid in the clinical assessment of adrenal status",
    "fda_folder": "Clinical Chemistry"
}